Cardiovascular therapy, diagnostic procedures, and control of risk factors in patients with diabetes or coronary artery disease in Poland: The Kardia-Pol registry

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 9, 2012, Pages 413-421

  Opolski, Grzegorz ^a   Strojek, Krzysztof ^b   Kurzelewski, Michał ^c   Ostrowski, Maciej ^c   Rabczenko, Daniel ^d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Sanofi Aventis Group Poland   (Poland)

^d NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Diagnostic procedures; Registry; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; SCREENING TEST; SYSTOLIC BLOOD PRESSURE;

EID: 84868665681     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1377     Document Type: Article

References (20)

1. [Clinical guidelines on the management of diabetic patients - 2009. Position statement of the Diabetes Poland]. Diabetologia Praktyczna. 2009; 9 (Suppl A): A1-A38. Polish.
2. Fox K, Garcia MA, Ardissino D, et al.; The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006; 27: 1341-1381. (Pubitemid 43998110)
3. Brown LC, Johnson JA, Majumdar SR, et al. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ. 2004; 171: 1189-1192. (Pubitemid 39518012)
4. Fu A, Zhang Q, Davies MJ, et al. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study. Curr Med Res Opin. 2011; 27: 1035-1040.
5. Rydén L, Standl E, Bartnik M, et al.; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28: 88-136. (Pubitemid 46137814)
6. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J. 2008; 29: 1316-1326. (Pubitemid 351768126)
7. Chrostowska M, Szyndler A, Paczwa P, Narkiewicz K. Impact of abdominal obesity on the frequency of hypertension and cardiovascular disease in Poland - results from the IDEA study (International day for the evaluation of abdominal obesity). Blood Press. 2011; 20: 145-152.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 (Suppl 1): S62-S69.
9. Gitt AK, Jünger C, Jannowitz C, et al. Adherence of hospital-based cardiologists to lipid guidelines in patients at high risk for cardiovascular events (2L registry). Clin Res Cardiol. 2011; 100: 277-287.
10. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32: 1769-1818.
11. Bała MM, Płaczkiewicz-Jankowska E, Topór- Ma̧dry R, et al. Characteristics of patients with type 2 diabetes of short duration in Poland: rationale, design and preliminary results of the ARETAEUS1 study. Pol Arch Med Wewn. 2009; 119: 533-540.
12. Banasiak W, Pociupany R, Wilkins A, Ponikowski P. Characteristics of patients with coronary artery disease managed on an outpatient basis in the population of Poland. Results of the multicentre RECENT trial. Kardiol Pol. 2007; 65: 132-140. (Pubitemid 46658355)
13. Śliż D, Mamcarz A, Filipiak KJ, et al. 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines. Pol Arch Med Wewn. 2010; 120: 328-333.
14. Michalak M, Kołtowski L, Jaworski R, et al. [Is treatment of hypercholesterolemia optimal? Results of the survey assessing ambulatory treatment of hypercholesterolemia in Poland]. Pol Przegl Kardiol. 2010; 12: 207-211. Polish.
15. Sacco M, Pellegrini F, Roncaglioni MC, et al.; PPP Collaborative Group. Primary prevention of cardiovascular events with low dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003; 26: 3264-3272. (Pubitemid 37466885)
16. Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. Br Med J. 2008; 337: a1840.
17. [Clinical guidelines on the management of diabetic patients - 2011. Position statement of the Diabetes Poland]. Diabetologia Praktyczna. 2011; 12 (Suppl A): A1-A46. Polish.
18. Cacoub PP, Zeymer U, Limbourg T, et al.; REACH Registry Investigators. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart. 2011; 97: 660-667.
19. Mancia G, Laurent S, Agabiti-Rosel E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009; 18: 308-347.
20. Widecka K, Grodzicki T, Narkiewicz K, et al. [Principles of management of arterial hypertension - 2011. Guidelines of Polish Society of Hypertension]. Nadciśnienie Tȩtnicze. 2011; 15: 55-82. Polish.